Peter J Goadsby Selected Research

Indomethacin (Indometacin)

5/2021	Indomethacin-responsive headaches-A narrative review.
1/2021	Differential actions of indomethacin: clinical relevance in headache.
10/2017	Noninvasive Vagus Nerve Stimulation for Treatment of Indomethacin-Sensitive Headaches.
1/2015	Postoperative hemicrania continua-like headache - a case series.
12/2012	A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization.
8/2012	Primary sex headache in adolescents.
8/2012	Trigeminal autonomic cephalalgias.
2/2011	Update on hemicrania continua.
12/2010	A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches.
7/2010	Hemicrania continua: a clinical study of 39 patients with diagnostic implications.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter J Goadsby Research Topics

Disease

197	Migraine Disorders (Migraine) 03/2022 - 03/2002
73	Headache (Headaches) 03/2022 - 05/2002
43	Cluster Headache (Cluster Headaches) 02/2022 - 05/2002
40	Pain (Aches) 01/2022 - 01/2003
19	Epilepsy (Aura) 01/2022 - 08/2005
12	Headache Disorders (Headache Syndromes) 05/2021 - 03/2003
11	Primary Headache Disorders 01/2021 - 05/2007
11	Nausea 01/2021 - 03/2004
10	Migraine with Aura (Familial Hemiplegic Migraine) 01/2022 - 03/2002
6	Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania) 01/2021 - 03/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2004
5	Ganglion Cysts (Ganglion) 01/2021 - 07/2016
5	Hyperacusis (Phonophobia) 01/2021 - 03/2004
5	Photophobia (Light Sensitivity) 01/2019 - 03/2004
4	visual snow syndrome 01/2022 - 06/2014
4	Hyperalgesia 01/2021 - 07/2011
4	Secondary Headache Disorders 01/2020 - 08/2006
3	Fatigue 01/2021 - 11/2014
3	Hypersensitivity (Allergy) 01/2021 - 10/2015
3	Erythema 01/2020 - 09/2014
3	Prescription Drug Overuse 01/2020 - 03/2010
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 09/2014
3	Vomiting 09/2017 - 11/2014
2	Mood Disorders (Mood Disorder) 01/2021 - 02/2012
2	Vertigo (Positional Vertigo) 01/2021 - 04/2016
2	Nasopharyngitis 01/2020 - 01/2018
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

53	Calcitonin Gene-Related PeptideIBA 03/2022 - 11/2002
38	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 03/2022 - 03/2004
34	Tryptamines (Triptans)IBA 03/2021 - 05/2002
26	Monoclonal AntibodiesIBA 01/2022 - 09/2014
17	erenumabIBA 01/2022 - 04/2016
15	Pharmaceutical PreparationsIBA 05/2021 - 09/2004
15	Indomethacin (Indometacin)FDA LinkGeneric 05/2021 - 09/2004
15	Serotonin (5 Hydroxytryptamine)IBA 04/2020 - 10/2004
15	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 11/2019 - 08/2004
14	Pain-FreeIBA 01/2021 - 01/2004
13	galcanezumabIBA 03/2021 - 09/2014
10	5-HT1F Serotonin ReceptorIBA 02/2022 - 11/2014
10	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 12/2014
10	Biological ProductsIBA 01/2021 - 08/2002
8	eptinezumabIBA 01/2022 - 11/2014
8	fremanezumabIBA 03/2021 - 07/2016
8	rimegepant sulfateIBA 01/2021 - 02/2014
8	salicylhydroxamic acid (SHAM)IBA 01/2020 - 04/2010
8	Dihydroergotamine (Agit)FDA LinkGeneric 07/2017 - 10/2011
7	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 11/2021 - 12/2014
7	Sumatriptan (Imigran)FDA LinkGeneric 01/2020 - 10/2004
7	Oxygen (Dioxygen)IBA 12/2012 - 10/2004
6	ubrogepantIBA 03/2021 - 01/2019
6	NeuropeptidesIBA 01/2021 - 03/2010
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 10/2002
6	Topiramate (Topamax)FDA LinkGeneric 03/2014 - 08/2005
6	Vasoconstrictor AgentsIBA 01/2014 - 10/2004
5	lasmiditanIBA 02/2022 - 01/2019
5	Peptides (Polypeptides)IBA 11/2021 - 12/2014
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2008
5	Glutamic Acid (Glutamate)FDA Link 01/2021 - 06/2009
4	OrexinsIBA 11/2021 - 05/2007
4	Analgesics (Analgesic Drugs)IBA 01/2021 - 03/2003
4	Acid Sensing Ion ChannelsIBA 01/2021 - 10/2012
4	atogepantIBA 01/2021 - 11/2019
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2005
4	telcagepantIBA 01/2020 - 02/2012
4	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2020 - 12/2014
4	Nitric Oxide Synthase (NO Synthase)IBA 11/2014 - 11/2002
4	Ion Channels (Ion Channel)IBA 05/2013 - 03/2002
4	Verapamil (Calan)FDA LinkGeneric 08/2012 - 04/2004
3	Therapeutic UsesIBA 02/2022 - 01/2005
3	Type A Botulinum Toxins (Botox)FDA Link 01/2022 - 12/2006
3	AntibodiesIBA 01/2021 - 09/2014
3	olcegepantIBA 01/2020 - 02/2012
3	2- (8- (3,5- difluorophenyl)- 10- oxo- 6,9- diazaspiro(4.5)dec- 9- yl)- N- (2'- oxo- 1,1',2',3- tetrahydrospiro(indene- 2,3'- pyrrolo(2,3- b)pyridin)- 5- yl)acetamideIBA 01/2020 - 04/2011
3	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 06/2007
3	Glutamate Receptors (Glutamate Receptor)IBA 03/2015 - 06/2009
3	Q-Type Calcium Channels (Q-Type Calcium Channel)IBA 04/2014 - 03/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 03/2014 - 09/2005
3	TRPV1 receptorIBA 11/2012 - 11/2007
3	Dopamine (Intropin)FDA LinkGeneric 06/2010 - 03/2007
3	zolmitriptan (Zomig)FDA Link 10/2009 - 01/2006
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2008 - 04/2003
2	Illicit Drugs (Recreational Drugs)IBA 01/2022 - 05/2014
2	Insulin (Novolin)FDA Link 11/2021 - 05/2017
2	LeptinIBA 11/2021 - 05/2017
2	Glucagon (Glukagon)FDA Link 11/2021 - 05/2017
2	Neuropeptide YIBA 11/2021 - 01/2016
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 06/2005
2	Memantine (Namenda)FDA Link 01/2021 - 01/2019
2	frovatriptan (Allegro)FDA Link 01/2021 - 09/2017
2	Hallucinogens (Psychedelics)IBA 11/2020 - 05/2014
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2018
2	Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2020 - 10/2015

Therapy/Procedure

76	Therapeutics 02/2022 - 09/2004
12	Vagus Nerve Stimulation 01/2021 - 03/2015
10	Transcranial Magnetic Stimulation 01/2021 - 04/2010
5	Aftercare (After-Treatment) 01/2020 - 12/2009
3	Contraindications 01/2021 - 09/2010
3	Drug Therapy (Chemotherapy) 11/2019 - 06/2009
3	Injections 09/2019 - 02/2014
3	Deep Brain Stimulation 06/2012 - 02/2008